Cardiac risks with COX-2 inhibitors [3]

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 4, 2007, Pages 489-492

  Ashworth, Andrew J ^a  

^a Davidson's Mains Medical Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CARDIOTOXICITY; CARDIOVASCULAR RISK; DRUG HALF LIFE; FITNESS; HUMAN; LETTER; PHYSICAL ACTIVITY;

EID: 33847743101     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1060144     Document Type: Letter

References (1)

1. Levesque LE, Brophy JM, Zhang B. Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors. CMAJ 2006;174(11): 1563-9.